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Background: The present study was undertaken to investigate the effects and underlying mechanism of ethanolic
extract of propolis (EEP) on the development of atherosclerotic lesions in ApoE−/− mice.
Methods: Eight-week-old male ApoE−/− mice fed a high-fat diet were treated with EEP (160 mg/kg/d) or vehicle
(the same dose) respectively for 14 weeks. The serum levels of total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C) and triglycerides (TG) were determined by enzymatic methods. Non-HDL-C was calculated as
TC minus HDL-C. Serum interleukin-6 (IL-6), interleukin-17 (IL-17), endothelin (ET), inducible nitric oxide synthase
(iNOS) and vascular endothelial growth factor (VEGF) were determined with enzyme-linked immunosorbent assay
methods. Nitric oxide (NO) content was measured with an enzymatic nitrate reductase assay. Analyses of
atherosclerotic lesions in whole aorta and aortic root sections were performed with plaque staining using Oil Red O.
Results: Compared with the vehicle-treated group, serum contents of total cholesterol (TC), triglycerides (TG) and
non-HDL-C reduced significantly by 31.88%, 21.01%, and 27.11% respectively in the EEP-treated group. Administration
of EEP decreased the level of IL-6 and increased the level of IL-17 in ApoE−/− mice with a high-fat diet. Compared with
the vehicle-treated group,EEP significantly reduced the levels of ET and VEGF,and showed a trend to increase NO and
inhibit iNOS. In the ApoE−/− mice fed a high-fat diet, EEP significantly reduced atherosclerotic lesion development in
the aortic root and whole aorta.
Conclusion: EEP can inhibit atherosclerotic lesion formation in ApoE−/− mice fed a high-fat diet possibly through
modulating cholesterol, regulating inflammatory reaction,inhibiting ET and VEGF, and protecting vascular
endothelial cells.
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Atherosclerotic disease is the main cause of death in
humans and presents long-term challenges for those
working in medical science. Sufficient evidence indicates
that inflammation plays an important role in the genesis,
development and progression of atherosclerosis (AS) [1,2].
The damage or dysfunction of vascular endothelial cells in-
duced by pro-inflammatory factors, especially dyslipidemia,
is the starting and key point of AS. Many clinical stud-
ies have demonstrated that impaired NO-dependent* Correspondence: shucunqin@hotmail.com
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reproduction in any medium, provided the orvasodilatation is closely related to atherosclerosis [3].
Hypercholesteremia is an independent and significant
risk factor of atherosclerosis. Lipid-lowering interventions
are the cornerstone for the prevention and treatment of
atherosclerosis. Thus, inhibiting inflammatory reaction and
improving the function of vascular endothelial cells is a vital
strategy to combat atherosclerotic lesion progression.
Propolis is a sticky substance made from plant saps
and resins, collected by honey bees and mixed by them
with wax flakes and pollen. Their salivary secretions join
with these compounds to create a unique substance with
a very complex chemical composition. The active ingredi-
ents are flavanoids. Previous studies show that propolis
possesses anti-inflammatory, antioxidant, immunomodu-
latory, anti- proliferative, antibacterial, and antiviral prop-
erties [4-7]. Koya-Miyata S et al. reported that propolisd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gain in diet-induced obesity in C57BL/6 N mice [8]. The
study by Nader MA et al., suggests that ethanolic extract of
propolis (EEP) produced protective effects on the develop-
ment of atherosclerosis in cholesterol-fed rabbits [9]. These
studies indicate that propolis may reduce the risk of AS
and have the potential of being anti-AS, and we believe this
evidence should be sustained through more experiments
in vivo. Therefore we observed the effects of EEP on ath-




16 eight-week-old male ApoE−/− mice were supplied by
the Laboratory Animal Center of Peking University,
weight 22 ± 2 g. The mice were kept in a temperature-
and humidity-controlled room with a 12/12 h light–dark
cycle. All experiments were approved by the Laboratory
Animals’ Ethical Committee of Taishan Medical University
and followed national guidelines for the care and use
of animals. All ApoE−/− mice were fed a Western-type
diet (21% fat and 0.15% cholesterol) and randomly di-
vided into 2 groups (n=8), the EEP group (treated with
EEP, 160 mg/kg/d) and the control, or model group
(treated with vehicle, same dose). Both EEP and vehicle
were administered intragastrically once daily for 14 weeks,
with dose adjustment weekly according to body weight.
Main reagents
The crude propolis was obtained from the Taishan bee yard
in China. EEP was extracted as described previously [8].
Interleukin-6 (IL-6), interleukin-17 (IL-17), endothelin (ET)
and vascular endothelial growth factor (VEGF) enzyme-
linked immunosorbent assay (ELISA) reagent kits were
purchased from R&D Systems Inc (Minnesota, USA),
Nitric oxide (NO) and inducible nitric oxide synthase
(iNOS) reagent kits were supplied by Nan-jing Jiancheng
Bioengineering Institute (Nanjing, China). Oil Red O was
obtained from Sigma-Aldrich Co. St. Louis (USA).
Serum analysis
After 14 weeks of treatment, blood was collected from the
retro-orbital sinus of all mice after a 12 h fasting period. The
serum levels of total cholesterol (TC), high density lipopro-
tein cholesterol (HDL-C), and triglycerides (TG) were deter-
mined by enzymatic methods. Non-HDL-C was calculated
as TC minus HDL-C. The serum levels of IL-6, IL-17, ET,
VEGF and iNOS were determined by ELISA kits. The serum
content of NO was measured by nitrate reductase method.
Lesion analysis
Following 14 weeks of treatment, the mice were anes-
thetized with an intraperitoneal injection of sodiumpentobarbital (40 mg/kg) and blood was collected. The
mice were sacrificed by exsanguination and perfused
with 10 ml ice-cold phosphate-buffered solution (PBS)
at physiological pressure via the left ventricle. The aortas
were isolated and the adventitia was thoroughly cleaned
under a dissecting microscope, they were then cut open
longitudinally and stained with Oil Red O. The percentage
of the plaque area stained by Oil Red O to the total luminal
surface area was determined.
To quantify the atherosclerotic lesions in the aortic
root, serial cryostat sections (8 μm) were prepared as
described previously [10]. In brief, atherosclerotic lesions
in the aortic root were examined at 3 locations and each
separated by 120 μm, 4 to 5 serial sections were prepared
from each location. The sections were stained with Oil Red
O and the lipid composition of the lesion was determined
by calculating the percent of the Oil Red O positive area to
the total cross-sectional vessel wall area. All images were
captured with an Olympus BX51 microscope equipped
with a video camera and analyzed using Image–Pro-Plus
6.0 software (version 6.0, Media Cybernetics, MD, USA). In
each case, the average value for 4 to 5 locations or sections
of each animal was used for analysis.Statistical analysis
Statistical analysis was performed by t-tests. Data were
expressed as means ± standard deviations (SD). P values
less than 0.05 were considered statistically significant.Results
EEP decreased atherosclerotic lesions in the aorta of
ApoE−/− mice
As shown in Figure 1, the orange-red area exhibits lipid
deposition in the aorta. In the EEP group, formation of
atherosclerotic lesions in cross-sections of the aortic
valve area decreased significantly by 25.26% compared
with the model group (Figures 1A, 1B, 1E). Oil Red O
staining revealed atherosclerotic plaque in the full length
of the aorta, distributed mainly in the aortic arch and
the areas surrounding the branching points of the major
arteries. EEP also reduced the aortic lesion area (lesion
area compared to total aortic area) by 16.17% compared
with the model group (Figures 1C, 1D, 1F).Effects of EEP on serum lipid in ApoE−/− mice
Figure 2 shows hyperlipidemia in the ApoE−/− mice,
induced by a high-fat diet for 14 weeks, and that
serum levels of TC, TG and non-HDL-C were significantly
reduced by 31.88%, 21.01%, and 27.11% respectively in the
EEP group, compared with the model group. However,
EEP had no significant effect on serum HDL-C compared
with the model group (the data was not shown).
Figure 1 EEP reduced atherosclerotic lesions in the aorta of ApoE−/− mice fed a high-fat diet. A, B Representative of Oil Red O-stained
aortic cross-sections. Orange-red area is lipid plaque, 10×4 magnification. A, model group; B, EEP group. C, D Representative of Oil Red O-stained
the full length of the aorta. Orange-red area is lipid plaque, 10×4 magnification. C, model group; D, EEP group. E. Quantitation of lesion areas in
Oil Red O-stained aortic cross-sections by Image-Pro Plus software. F, Quantitation of atherosclerotic lesions in the full length of the aorta by
Image-Pro Plus software. *P<0.05 versus model group. EEP, ethanolic extract of propolis.
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in ApoE−/− mice fed a high-fat diet
As shown in Figures 3A, 3B, 3C, the serum concentrations
of ET decreased significantly by 20.96% in the EEP group
compared with the model group (65.72 versus 83.15 ng/L).
Supplementation with EEP (160 mg/kg/d) increased
NO and decreased iNOS, yet no statistical significance
was observed.
In the present study, serum concentration of VEGF
expression was detected by ELISA. As shown in Figure 3D,Figure 2 Effects of EEP on serum lipid in ApoE−/− mice fed a high-fat
period with EEP (160 mg/kg/d) in ApoE−/− mice on a high-fat diet. A, total
(mmol/L). Data are presented as means ± SD (n=8 per group). *P<0.05 vers
lipoprotein cholesterol.supplementation with EEP (160 mg/kg/d) in ApoE−/−
mice fed a high-fat diet significantly inhibited VEGF by
28.45% compared with the model group (124.05 versus
173.37 ng/L).
As shown in Figures 3E, 3F, supplementation with
EEP (160 mg/kg/d) in ApoE−/− mice fed a high-fat diet
significantly decreased the level of IL-6 by 25.30%
(10.48 versus 14.03 pg/ml) and increased the level of
IL-17 by 18.77% (8.64 versus 7.27 pg/ml), compared
with the model group.diet. Serum lipid concentrations after a 14-week supplementation
cholesterol (mmol/L); B, triglycerides (mmol/L); C, non-HDL-C
us model group. EEP, ethanolic extract of propolis; HDL-C, high-density
Figure 3 Effects of EEP on serum ET, NO, iNOS, VEGF, IL-6 and IL-17 in ApoE−/− mice fed a high-fat diet. Serum concentrations of ET, NO,
iNOS, VEGF, IL-6 and IL-17 after a 14-week supplementation period with EEP (160 mg/kg/d) in ApoE−/− mice on a high-fat diet. A, ET (ng/L);
B, NO (umol/L); C, iNOS (U/mL); D, VEGF (ng/L); E, IL-6 (pg/ml); F, IL-17 (pg/ml). Data are presented as means ± SD (n=8 per group). *P<0.05;
**P<0.01 versus model group. EEP, ethanolic extract of propolis; ET, endothelin; NO, nitric oxide; iNOS, inducible nitric oxide synthase; VEGF,
vascular endothelial growth factor; IL-6, interleukin-6; IL-17, interleukin-17.
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A number of studies have demonstrated that propolis
may possibly inhibit atherosclerosis. Fuliang Hu et al.
[11] and Nader MA et al. [9] respectively confirmed with
rat and rabbit models that propolis can reduce atheroscler-
otic lesion formation. In the present study,we used ApoE−/−
mice to observe the effects of EEP on atherosclerotic
lesions and to explore the underlying mechanism. The
ApoE−/− mouse, a recognized atherosclerosis animal model,
can spontaneously develop atherosclerosis with features
similar to those observed in human hyperlipoproteinemia.
These lesions may develop even with a normal diet, while a
high fat diet can accelerate atherosclerotic lesion formation
[12]. Our present study has shown that EEP can inhibit ath-
erosclerotic lesion formation in whole aorta and aortic root
sections in ApoE−/− mice fed a high-fat diet. The possible
mechanisms may be mediated by modulating cholesterol,
regulating inflammatory reactions, inhibiting ET and VEGF
expression, and protecting vascular endothelial cells.
Hypercholesterolemia is recognized as a risk factor for
atherosclerosis. Propolis may possibly protect against
atherosclerosis by regulating cholesterol. Fuliang Hu et al.
[11] and Nader MA et al., [9] reported on Sprague Dawley
rats and New Zealand rabbit models respectively, that
propolis can decrease TC, TG and LDL-C. Koya-Miyata S
et al. reported that propolis prevents diet-induced hyperlip-
idemia and mitigates weight gain in diet-induced obesity in
C57BL/6 N mice [8]. Our results showed that EEP signifi-
cantly inhibited TC, TG and non-HDL-C in ApoE−/− mice
fed a high-fat diet. The fact that EEP can significantly in-
hibit AS suggests that the modulation of lipid metabolism
contributes to the anti-atherogenic effect of EEP.Atherosclerosis is considered a chronic inflammatory
disease [1]. Inflammatory reactions exist throughout
the atherosclerosis process. IL-6, an inflammation
pre-stimulation monokine secreted by mononuclear-
macrophages with moderate inflammatory activity, is
strongly associated with atherosclerosis and its pro-
gression [13]. In rats with Freund’s complete adjuvant
induced arthritis, propolis extracts significantly inhibited
the increase of IL-6 in inflammatory tissues [5]. Recently,
a new lineage of CD4+ T cells, type 17 helper T cells
producing the signature cytokines IL-17, IL-21, and IL-22,
has been identified [14]. The relevance of IL-17 to hu-
man atherosclerosis remains poorly defined because of
conflicting results in animal studies [15]. An up-to-
date study by Simon T et al. [16] found that elevated
levels of IL-17 are associated with a better outcome in
patients with acute myocardial infarction, supporting a
protective regulatory role of IL-17 in coronary heart
disease,whereas IL-6 levels were associated with a worse
outcome despite the fact that IL-6 and IL-17 might induce
each other. Our study showed that administration with EEP
significantly decreased the level of IL-6 and increased the
level of IL-17 in ApoE−/− mice on a high-fat diet. Therefore
in the early stages of atherosclerosis,inhibition of IL-6 and
elevation of IL-17 by EEP might be one mechanism of its
anti-AS effects.
The damage or dysfunction of vascular endothelial cells,
induced by various kinds of proinflammatory factors espe-
cially dyslipidemia,is the initial and key point of atheroscler-
osis. The disequilibrium of endothelin (ET) and nitric oxide
(NO) is the main cause of endothelial function disorder.
ET-1, a 21-amino acid peptide with strong vasoconstrictor
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lecular form of endothelium involved in the formation
of artherosclerosis. NO might inhibit all key processes
participating in the early pathogenesis. Active iNOS
can be found at early stages of atherosclerotic plaque,
which leads to nitration of NO and finally aggravates
AS [18]. Our results showed that EEP can significantly
reduce the levels of serum ET, and meanwhile show a
trend to increase NO and inhibit iNOS, although not
with statistical significance. These results indicate that
EEP might reverse the unfavorable imbalance between
NO and ET.
Vascular endothelial growth factor (VEGF), an endothelial
specific growth and chemotactic factor, can be synthesized
by various cell types including macrophages, T lymphocytes
and mast cells [19]. In unstable human coronary plaques,
there is an increased neovascularization, which prob-
ably induced by VEGF-A [20]. Pelisek J et al. found a
close association between neovascularization, expression of
VEGF, inflammation, and plaque vulnerability in patients
with advanced carotid stenosis [21]. Our results showed
that EEP significantly reduced the levels of serum VEGF in
ApoE−/− mice on a high-fat diet,which indicates that EEP
may reduce the quantity of developing neovascularization
and thus stabilize the plaque.Conclusions
In conclusion, we believe that EEP can inhibit athero-
sclerotic lesion formation in ApoE−/− mice fed a high-fat
diet, possibly through modulating cholesterol, regulating
inflammatory reactions,inhibiting ET and VEGF, and
protecting vascular endothelial cells. More detailed
mechanisms need to be investigated.
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